Kevin OGallagher
Overview
Explore the profile of Kevin OGallagher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
739
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shooshtarian A, OGallagher K, Shah A, Zhang M
Heart Fail Rev
. 2025 Jan;
PMID: 39843817
With rising incidence, mortality and limited therapeutic options, heart failure with preserved ejection fraction (HFpEF) remains one of the most important topics in cardiovascular medicine today. Characterised by left ventricular...
2.
Demir O, Rahman H, De Silva K, Scannell C, Ryan M, OGallagher K, et al.
JACC Cardiovasc Interv
. 2025 Jan;
18(2):279-281.
PMID: 39797835
No abstract available.
3.
Scott J, Johnson T, Caskey F, Bailey P, Selman L, Mulla A, et al.
Open Heart
. 2024 Oct;
11(2).
PMID: 39384342
Background: Reduced estimated glomerular filtration rate (eGFR) is associated with lower use of invasive management and increased mortality after acute coronary syndrome (ACS). The reasons for this are unclear. Methods:...
4.
McGarvey M, Lam L, Razak M, Barraclough J, OGallagher K, Webb I, et al.
EuroIntervention
. 2024 Sep;
20(18):e1184-e1194.
PMID: 39279513
Background: Recent observations in silico and in vivo reported that, during proximal optimisation technique, drug-eluting stents (DES) elongate, challenging conventional wisdom. The interaction between plaque morphology and radial expansion is...
5.
Mahmod M, Chan K, Fernandes J, Ariga R, Raman B, Zacur E, et al.
Circ Cardiovasc Imaging
. 2024 Aug;
17(8):e016489.
PMID: 39163368
Background: Left ventricular (LV) hypertrophy occurs in both aortic stenosis (AS) and systemic hypertension (HTN) in response to wall stress. However, differentiation of hypertrophy due to these 2 etiologies is...
6.
Brown S, Biswas D, Wu J, Ryan M, Bernstein B, Fairhurst N, et al.
JACC Adv
. 2024 Jul;
3(8):101064.
PMID: 39050815
Background: Heart failure with preserved ejection fraction (HFpEF) is the predominant form of HF in older adults. It represents a heterogenous clinical syndrome that is less well understood across different...
7.
Soltani F, Jenkins D, Kaura A, Bradley J, Black N, Farrant J, et al.
BMC Cardiovasc Disord
. 2024 Jul;
24(1):343.
PMID: 38969974
Background: Heart failure (HF) with preserved or mildly reduced ejection fraction includes a heterogenous group of patients. Reclassification into distinct phenogroups to enable targeted interventions is a priority. This study...
8.
Chammas L, Yuan K, Little S, Roadknight G, Varnai K, Chang S, et al.
Front Cardiovasc Med
. 2024 Jun;
11:1406608.
PMID: 38836064
Objective: The COVID-19 pandemic was associated with a reduction in the incidence of myocardial infarction (MI) diagnosis, in part because patients were less likely to present to hospital. Whether changes...
9.
Watson S, Mohanan S, Abdrazak M, Roy R, Parczewska A, Kanyal R, et al.
Eur Heart J Acute Cardiovasc Care
. 2024 May;
13(8):605-614.
PMID: 38805012
Aims: We validated the CREST model, a 5 variable score for stratifying the risk of circulatory aetiology death (CED) following out-of-hospital cardiac arrest (OHCA) and compared its discrimination with the...
10.
Kelber M, Smolenski D, Belsher B, OGallagher K, Issa F, Stewart L, et al.
Pain
. 2024 May;
165(11):e138-e144.
PMID: 38709494
Given the high rates of physical trauma and pain among service members, opioid-prescribing practices and use patterns have significant implications for the well-being of service members and can affect military...